Sanitar Co., Ltd. (1817.TW)
TWD 40.85
(-0.61%)
TWD 40.85
(-0.61%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.5 Billion TWD | -6.32% |
| 2022 | 2.66 Billion TWD | 12.52% |
| 2021 | 2.37 Billion TWD | 2.87% |
| 2020 | 2.3 Billion TWD | -1.22% |
| 2019 | 2.33 Billion TWD | 1.82% |
| 2018 | 2.29 Billion TWD | 1.02% |
| 2017 | 2.26 Billion TWD | 2.14% |
| 2016 | 2.22 Billion TWD | 0.86% |
| 2015 | 2.2 Billion TWD | 13.11% |
| 2014 | 1.94 Billion TWD | 12.15% |
| 2013 | 1.73 Billion TWD | 20.63% |
| 2012 | 1.43 Billion TWD | 4.5% |
| 2011 | 1.37 Billion TWD | -1.08% |
| 2010 | 1.39 Billion TWD | 17.24% |
| 2009 | 1.18 Billion TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 575.63 Million TWD | -19.37% |
| 2024 Q2 | 722.57 Million TWD | 25.53% |
| 2023 Q3 | 630.92 Million TWD | -3.2% |
| 2023 Q1 | 504.19 Million TWD | -28.59% |
| 2023 Q2 | 651.78 Million TWD | 29.27% |
| 2023 FY | 2.5 Billion TWD | -6.32% |
| 2023 Q4 | 713.92 Million TWD | 13.16% |
| 2022 Q3 | 684.21 Million TWD | -1.96% |
| 2022 Q1 | 581.41 Million TWD | -15.89% |
| 2022 FY | 2.66 Billion TWD | 12.52% |
| 2022 Q4 | 706.08 Million TWD | 3.2% |
| 2022 Q2 | 697.9 Million TWD | 20.04% |
| 2021 Q3 | 505.41 Million TWD | -17.93% |
| 2021 Q2 | 615.8 Million TWD | 9.93% |
| 2021 Q1 | 560.19 Million TWD | -10.16% |
| 2021 Q4 | 691.22 Million TWD | 36.76% |
| 2021 FY | 2.37 Billion TWD | 2.87% |
| 2020 FY | 2.3 Billion TWD | -1.22% |
| 2020 Q1 | 481.6 Million TWD | -30.74% |
| 2020 Q2 | 585.03 Million TWD | 21.48% |
| 2020 Q3 | 616.33 Million TWD | 5.35% |
| 2020 Q4 | 623.54 Million TWD | 1.17% |
| 2019 Q2 | 589.15 Million TWD | 18.74% |
| 2019 Q1 | 496.16 Million TWD | -19.67% |
| 2019 FY | 2.33 Billion TWD | 1.82% |
| 2019 Q4 | 695.4 Million TWD | 25.48% |
| 2019 Q3 | 554.2 Million TWD | -5.93% |
| 2018 FY | 2.29 Billion TWD | 1.02% |
| 2018 Q4 | 617.68 Million TWD | 7.55% |
| 2018 Q3 | 574.3 Million TWD | 1.0% |
| 2018 Q2 | 568.63 Million TWD | 6.79% |
| 2018 Q1 | 532.48 Million TWD | -15.4% |
| 2017 Q1 | 493.24 Million TWD | -20.56% |
| 2017 Q2 | 567.48 Million TWD | 15.05% |
| 2017 Q3 | 579.83 Million TWD | 2.18% |
| 2017 Q4 | 629.4 Million TWD | 8.55% |
| 2017 FY | 2.26 Billion TWD | 2.14% |
| 2016 FY | 2.22 Billion TWD | 0.86% |
| 2016 Q4 | 620.91 Million TWD | 12.94% |
| 2016 Q1 | 505.72 Million TWD | -21.31% |
| 2016 Q2 | 546.07 Million TWD | 7.98% |
| 2016 Q3 | 549.76 Million TWD | 0.68% |
| 2015 Q2 | 534.82 Million TWD | 10.63% |
| 2015 FY | 2.2 Billion TWD | 13.11% |
| 2015 Q4 | 642.7 Million TWD | 18.47% |
| 2015 Q3 | 542.5 Million TWD | 1.44% |
| 2015 Q1 | 483.44 Million TWD | -13.95% |
| 2014 Q1 | 390.44 Million TWD | -24.62% |
| 2014 FY | 1.94 Billion TWD | 12.15% |
| 2014 Q2 | 490.03 Million TWD | 25.51% |
| 2014 Q4 | 561.8 Million TWD | 11.08% |
| 2014 Q3 | 505.76 Million TWD | 3.21% |
| 2013 FY | 1.73 Billion TWD | 20.63% |
| 2013 Q4 | 517.96 Million TWD | 17.13% |
| 2013 Q2 | 426.37 Million TWD | 21.67% |
| 2013 Q1 | 350.43 Million TWD | -16.46% |
| 2013 Q3 | 442.2 Million TWD | 3.71% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 Q4 | 419.48 Million TWD | 15.46% |
| 2012 Q3 | 363.31 Million TWD | 0.0% |
| 2012 FY | 1.43 Billion TWD | 4.5% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | 1.37 Billion TWD | -1.08% |
| 2011 Q2 | - TWD | 0.0% |
| 2010 FY | 1.39 Billion TWD | 17.24% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | 1.18 Billion TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Farcent Enterprise Co.,Ltd | 2.62 Billion TWD | 4.628% |
| Mao Bao Inc. | 554.25 Million TWD | -351.203% |
| Taiyen Biotech Co., Ltd. | 3.4 Billion TWD | 26.636% |
| Chlitina Holding Limited | 4.53 Billion TWD | 44.852% |
| Jourdeness Group Limited | 2.97 Billion TWD | 15.959% |
| Nan Liu Enterprise Co., Ltd. | 6.17 Billion TWD | 59.527% |
| Luo Lih-Fen Holding Co., Ltd. | 971.05 Million TWD | -157.539% |
| San Neng Group Holdings Co., Ltd. | 1.9 Billion TWD | -31.219% |
| Yuen Foong Yu Consumer Products Co., Ltd. | 10.26 Billion TWD | 75.637% |
| KNH Enterprise Co., Ltd. | 2.93 Billion TWD | 14.887% |